Other study, using targeted-sequencing, concluded that genetic variants in genes such as CTNNA1 or MYD88 are infrequent in EOGC patients and discarded MAP3K6 as a candidate gene in GC predisposition [18]. This evidence concerns the gene MAP3K6 and gastric cancer.